| Title |
Do Statins Impair Cognition? A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
|---|---|
| Published in |
Journal of General Internal Medicine, January 2015
|
| DOI | 10.1007/s11606-014-3115-3 |
| Pubmed ID | |
| Authors |
Brian R. Ott, Lori A. Daiello, Issa J. Dahabreh, Beth A. Springate, Kimberly Bixby, Manjari Murali, Thomas A. Trikalinos |
| Abstract |
In 2012, the United States Food and Drug Administration (FDA) issued a warning regarding potential adverse effects of HMG-CoA reductase inhibitors (statins) on cognition, based on the Adverse Events Reporting System and a review of the medical literature. We aimed to synthesize randomized clinical trial (RCTs) evidence on the association between statin therapy and cognitive outcomes. |
X Demographics
The data shown below were collected from the profiles of 38 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 21% |
| Spain | 7 | 18% |
| Canada | 2 | 5% |
| Andorra | 1 | 3% |
| Argentina | 1 | 3% |
| Romania | 1 | 3% |
| Australia | 1 | 3% |
| United Kingdom | 1 | 3% |
| Netherlands | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 15 | 39% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 27 | 71% |
| Scientists | 4 | 11% |
| Practitioners (doctors, other healthcare professionals) | 4 | 11% |
| Science communicators (journalists, bloggers, editors) | 3 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Unknown | 161 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 17% |
| Other | 22 | 14% |
| Student > Master | 17 | 10% |
| Student > Ph. D. Student | 13 | 8% |
| Student > Bachelor | 12 | 7% |
| Other | 40 | 25% |
| Unknown | 30 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 52 | 32% |
| Psychology | 21 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 10% |
| Neuroscience | 7 | 4% |
| Nursing and Health Professions | 6 | 4% |
| Other | 24 | 15% |
| Unknown | 36 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 147. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 February 2024.
All research outputs
#284,906
of 25,732,188 outputs
Outputs from Journal of General Internal Medicine
#236
of 8,246 outputs
Outputs of similar age
#3,227
of 360,229 outputs
Outputs of similar age from Journal of General Internal Medicine
#2
of 140 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,246 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 360,229 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 140 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.